Company Announcements MR Solutions appointed AXT as a distributor for Australia in February. Quanterix appointed SCRUM as its exclusive Japanese distributor for the research market in March. In April, NanoString Technologies and the University of Texas MD Anderson Cancer Center entered into a multiyear collaboration to develop “multi-omic” assays to simultaneously profile both gene and […]

Company Announcements PointCross Life Sciences announced in April a strategic partnership with InterpretOmics to integrate their respective RDIS and iOmics platforms across nonclinical, clinical and genomic biomarkers for targeted drug development and patient stratification. In May, Pacific Biosciences and RainDance Technologies partnered to codevelop and comarket novel solutions for de novo whole genome assembly. These […]

As part of its “Japan is Back” strategy for economic growth, the Japanese government plans to promote technological innovation by setting up a system of research universities to partner with start-up companies. The goal is to stimulate the generation of new companies from universities. The government also plans a system of graduate schools to collaborate […]

For fiscal 2015, the Turkish government’s preliminary R&D allocations totaled TRY 5,850 million ($2,140 million), rising 4.3%. Indirect R&D support (tax incentives, exemptions, reductions in wage taxes for R&D workers and social security contributions) were projected at TRY 1,491 million, up 9.6%. At 40%, R&D from General University Funds (GUF) for “general advancement of knowledge” […]

Following the recall in India of Nestle’s Maggi noodles for higher-than-permitted levels of lead and MSG, the Food Safety and Standards Authority of India (FSSAI) has requested that states step up their monitoring of milk, packaged drinking water and edible oils. It has also asked food commissioners to increase testing of these products. The FSSAI […]

In the US, Europe, Australia and Canada, 2014 biotech sales totaled $123.1 billion, rising 24.3%, with each country or region accounting for 76%, 19%, 5% and 0.2% of sales, respectively. Sales of Gilead Science’s hepatitis C drugs accounted for a sizable portion of revenues in 2014; adjusting for Gilead, growth for the industry was 12%. […]

By the University of Manchester’s estimates, $2.4 billion has been invested in graphene research. In 2014, Lux Research projected a 2025 global market of $349 million for the material; however, in 2013, sales of graphene totaled only $12 million. Manufacture of the material has accelerated, with total production capacity of graphene nanoplatelets in the Americas; […]